Lisata Therapeutics, Inc.
Price Action
Technical Summary
EMERGING TRENDLisata Therapeutics, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 74), indicating performance broadly in line with the market. Earnings growth of 9% provides fundamental context to the price action. Investors should exercise caution due to high volatility (109% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $3.46 | -2.89% | BELOW |
| 50 SMA | $3.31 | +1.60% | ABOVE |
| 100 SMA | $4.02 | -16.36% | BELOW |
| 150 SMA | $3.49 | -3.78% | BELOW |
| 200 SMA | $3.22 | +4.49% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is LSTA in an uptrend right now?
LSTA has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is LSTA overbought or oversold?
LSTA's RSI (14) is 46. The stock is in neutral territory, neither overbought nor oversold.
Is LSTA outperforming the market?
LSTA has a Relative Strength (RS) Rating of 74 out of 99. LSTA is performing about average compared to the market.
Where is LSTA in its 52-week range?
LSTA is trading at $3.36, which is 66% of its 52-week high ($5.07) and 48% above its 52-week low ($1.81).
How volatile is LSTA?
LSTA has a Beta of 0.75 and 52-week volatility of 109%. It's less volatile than the S&P 500 - generally more stable.